GlassScriptPhysician profile
Autumn H Jackson
NPI 1477739100
$2,819.62
in general payments reported to CMS, 2019-2025
17 companies · $486 in 2025
The $486 reported for 2025 was more than what 76% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $129 · 2021: $177 · 2022: $596 · 2023: $812 · 2024: $391 · 2025: $486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,688.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $399.39 | 2022-2025 | Tyrvaya, Ryzumvi |
| Sun Pharmaceutical Industries INC. | $388.61 | 2021-2025 | Cequa |
| Novartis Pharmaceuticals Corporation | $325.72 | 2019-2023 | |
| Bausch & Lomb Americas INC. | $312.28 | 2022-2025 | Miebo, Xiidra, Envista Mx60 Iol |
| Alcon Vision LLC | $258.98 | 2019-2025 | Total30, Precision7, Tryptyr |
| Biotissue Holdings INC. | $236.24 | 2023-2024 | |
| Sight Sciences, INC. | $173.96 | 2019-2022 | |
| Abbvie INC. | $157.05 | 2022-2025 | |
| Johnson & Johnson Vision Care, INC. | $105.30 | 2019-2025 | Acuvue |
| Kala Pharmaceuticals, INC. | $94.60 | 2019-2021 | |
| Menicon America INC | $79.97 | 2019-2020 | |
| Tarsus Pharmaceuticals, INC. | $68.09 | 2024-2025 | Xdemvy |
| Allergan, INC. | $64.48 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $54.99 | 2019-2020 | |
| Shire North American Group INC | $39.23 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $32.29 | 2023-2024 | Myday Contact Lens |
| Rayner Intraocular Lenses Limited | $28.44 | 2023-2025 | Omidria, Rayone Spheric, Rayone Aspheric |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Autumn Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.